443 related articles for article (PubMed ID: 19451348)
1. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.
Yan J; Young ME; Cui L; Lopaschuk GD; Liao R; Tian R
Circulation; 2009 Jun; 119(21):2818-28. PubMed ID: 19451348
[TBL] [Abstract][Full Text] [Related]
2. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
3. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
[TBL] [Abstract][Full Text] [Related]
4. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice.
Pellieux C; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
Am J Physiol Heart Circ Physiol; 2012 May; 302(9):H1795-805. PubMed ID: 22408021
[TBL] [Abstract][Full Text] [Related]
6. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
Lahey R; Wang X; Carley AN; Lewandowski ED
Circulation; 2014 Nov; 130(20):1790-9. PubMed ID: 25266948
[TBL] [Abstract][Full Text] [Related]
7. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
[TBL] [Abstract][Full Text] [Related]
8. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis.
Atkinson LL; Fischer MA; Lopaschuk GD
J Biol Chem; 2002 Aug; 277(33):29424-30. PubMed ID: 12058043
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress.
Luptak I; Yan J; Cui L; Jain M; Liao R; Tian R
Circulation; 2007 Aug; 116(8):901-9. PubMed ID: 17679614
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-CoA carboxylase control of fatty acid oxidation in hearts from hibernating Richardson's ground squirrels.
Belke DD; Wang LC; Lopaschuk GD
Biochim Biophys Acta; 1998 Mar; 1391(1):25-36. PubMed ID: 9518540
[TBL] [Abstract][Full Text] [Related]
11. Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart.
Liu Z; Ding J; McMillen TS; Villet O; Tian R; Shao D
J Mol Cell Cardiol; 2020 Sep; 146():1-11. PubMed ID: 32592696
[TBL] [Abstract][Full Text] [Related]
12. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.
Wright JJ; Kim J; Buchanan J; Boudina S; Sena S; Bakirtzi K; Ilkun O; Theobald HA; Cooksey RC; Kandror KV; Abel ED
Cardiovasc Res; 2009 May; 82(2):351-60. PubMed ID: 19147655
[TBL] [Abstract][Full Text] [Related]
14. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
[TBL] [Abstract][Full Text] [Related]
15. Diet-induced obese mouse hearts tolerate an acute high-fatty acid exposure that also increases ischemic tolerance.
Boardman NT; Pedersen TM; Rossvoll L; Hafstad AD; Aasum E
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H682-H693. PubMed ID: 32795177
[TBL] [Abstract][Full Text] [Related]
16. Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.
Ritterhoff J; McMillen TS; Villet O; Young S; Kolwicz SC; Senn T; Caudal A; Tian R
J Mol Cell Cardiol; 2021 Sep; 158():1-10. PubMed ID: 33989657
[TBL] [Abstract][Full Text] [Related]
17. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
Luptak I; Balschi JA; Xing Y; Leone TC; Kelly DP; Tian R
Circulation; 2005 Oct; 112(15):2339-46. PubMed ID: 16203912
[TBL] [Abstract][Full Text] [Related]
18. The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis.
Moellmann J; Mann PA; Kappel BA; Kahles F; Klinkhammer BM; Boor P; Kramann R; Ghesquiere B; Lebherz C; Marx N; Lehrke M
Diabetes Obes Metab; 2022 Nov; 24(11):2263-2272. PubMed ID: 35801343
[TBL] [Abstract][Full Text] [Related]
19. Adverse cardiac remodeling augments adipose tissue ß-adrenergic signaling and lipolysis counteracting diet-induced obesity.
Kolleritsch S; Pajed L; Tilp A; Hois V; Pototschnig I; Kien B; Diwoky C; Hoefler G; Schoiswohl G; Haemmerle G
J Biol Chem; 2023 Jun; 299(6):104788. PubMed ID: 37150323
[TBL] [Abstract][Full Text] [Related]
20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
